<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04547296</url>
  </required_header>
  <id_info>
    <org_study_id>XJTU1AF2020LSK-071</org_study_id>
    <nct_id>NCT04547296</nct_id>
  </id_info>
  <brief_title>Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy</brief_title>
  <official_title>Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy: a Multicenter, Randomized and Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Qinghai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Xinjiang Uygur Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A variety of reasons lead to a sharp increase in lactic acid levels in patients undergoing&#xD;
      liver resection, while leading to hyperlactic acidemia, resulting in decreased cardiac&#xD;
      output, elevated blood potassium, and response to catecholamines and insulin Damage,&#xD;
      increased risk of kidney damage, poor recovery of liver function, decreased immune function,&#xD;
      and prolonged hospital stay. Sodium bicarbonate Ringer injection does not contain lactic&#xD;
      acid. HCO3- is metabolized by acid-base neutralization in body fluids, and 90% is CO2 The&#xD;
      form is excreted from the body by breathing, and only 10% HCO3- is metabolized by the kidney,&#xD;
      without the burden of liver metabolism. Physiological concentration of Cl- avoids perchloric&#xD;
      acidosis and kidney damage; physiological concentration of Ca2+ and Mg2+ help maintain the&#xD;
      body's electrolyte balance and reduce stress-related arrhythmia.The smooth development of&#xD;
      this study will help refine the intraoperative fluid management strategy, improve the&#xD;
      patient's intraoperative tissue perfusion, maintain the body's acid-base and electrolyte&#xD;
      balance, reduce postoperative kidney damage, and improve the patient's quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study intends to carry out a high-quality clinical research with design specifications,&#xD;
      large sample, multi-center, randomized and controlled methods. From October 9, 2020 to&#xD;
      October 9, 2022, participants undergoing hepatectomy surgery under general anesthesia will be&#xD;
      recruited. Participants will be randomly assigned, in a 1:1 ratio, to receive Sodium&#xD;
      bicarbonate Ringer's solution or control (Acetate Ringer's solution). The randomization&#xD;
      sequence will be computer-generated, and randomization will be performed in blocks and will&#xD;
      be stratified according to participating center. After entering the operating room, the two&#xD;
      groups were pre-dilated with sodium bicarbonate Ringer or acetate Ringer (30 min, 8 ml/kg).&#xD;
      After the operation started, the two groups of participants were maintained with 4-5 ml/kg/h&#xD;
      Ringer's solution during the operation. Blood gas index (but are not limited to these data)&#xD;
      at intraoperative will be recorded. At the same time, other dates will be recorded.The&#xD;
      participation of each patient is scheduled for 1 month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 9, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intraoperative hyperlactacidemia</measure>
    <time_frame>During the operation</time_frame>
    <description>Diagnostic criteria: Lac ≥ 2 mmol/L, pH ≤ 7.35, HCO3- ≤ 20 mmol/L, PaCO2 &lt;50 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of blood gas index disorder</measure>
    <time_frame>During the operation</time_frame>
    <description>Blood gas was monitored every hour during the operation and the incidence of intraoperative blood gas index disorder was recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative acute kidney injury</measure>
    <time_frame>Day 2 after the operation</time_frame>
    <description>The incidence of acute kidney injury within 48h after surgery was recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of postoperative complications</measure>
    <time_frame>Day 30 after the operation</time_frame>
    <description>postoperative complications: cardiovascular complications; pulmonary complications; infection complications; other complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">484</enrollment>
  <condition>Hyperlactacidemia</condition>
  <arm_group>
    <arm_group_label>BRS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After entering the operating room, this group were pre-dilated with sodium bicarbonate ringer's solution (30 min, 8 ml/kg), and maintained with 4-5 ml/kg/h sodium bicarbonate ringer's solution during the operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ARS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After entering the operating room, this group were pre-dilated with acetate ringer ringer's solution (30 min, 8 ml/kg), and maintained with 4-5 ml/kg/h acetate ringer's solution during the operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Bicarbonate Ringer's Solution</intervention_name>
    <description>After the participants enter the operating room, radial artery puncture and catheterization were performed. The blood gas in the non-oxygen state was used as the basic value. A peripheral venous access was established in one upper limb, and the two groups were pre-dilated with sodium bicarbonate Ringer's solution or acetate Ringer's solution (30 min, 8 ml/kg). For laparoscopic surgery, adjust the PaCO2 value to 35-45 mmHg again 10 minutes after the establishment of the pneumoperitoneum. After the operation started, the two groups of participants were maintained with 4-5 ml/kg/h Ringer's solution during the operation. Blood gas was measured every hour after tracheal intubation during the operation, and the last blood gas was measured when the skin was sutured. When the blood gas pH &lt;7.2, 5% sodium bicarbonate injection was given to correct it.</description>
    <arm_group_label>ARS group</arm_group_label>
    <arm_group_label>BRS group</arm_group_label>
    <other_name>Acetate Ringer's Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients for selective liver surgery under general anesthesia&#xD;
&#xD;
          2. Age &gt; 18 year，BMI 18 - 40 kg/m2，American society of Anesthesiologists (ASA) grade are&#xD;
             between I - III&#xD;
&#xD;
          3. Ability to understand, sign informed consent and cooperate with the intervention and&#xD;
             evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Abnormal renal function：blood creatinine (Cr) and / or urea nitrogen (BUN)&gt; upper&#xD;
             limit of normal value; Patients with underlying kidney disease; patients with&#xD;
             congenital kidney malformations.&#xD;
&#xD;
          2. In patients with respiratory failure, arterial blood oxygen partial pressure (PaO2) &lt;&#xD;
             60 mmHg, or accompanied by carbon dioxide partial pressure (PaCO2)&gt; 50mmHg; blood&#xD;
             oxygen saturation (SpO2) &lt; 90%.&#xD;
&#xD;
          3. A history of myocardial infarction within 6 months before the screening period;&#xD;
             history of severe circulatory or respiratory diseases; history of autoimmune diseases;&#xD;
             patients with mental illness or neurological disorders that cannot be expressed&#xD;
             exactly; patients with a history of epilepsy; patients with pulmonary edema or&#xD;
             congestive heart failure.&#xD;
&#xD;
          4. Severe hypercalcemia (Ca2+ &gt; 2.75 mmol/L), hypernatremia (Na+ &gt; 155 mmol/L),&#xD;
             hyperkalemia (K+ &gt; 5.5 mmol/L), hyperchloremia (Cl- &gt; 110 mmol/L), Hypermagnesium&#xD;
             (Mg2+ &gt; 1.25 mmol/L).&#xD;
&#xD;
          5. Patients with a history of hypothyroidism; pregnant or lactating women.&#xD;
&#xD;
          6. Patients with a history of adverse blood transfusion reactions; those who refuse blood&#xD;
             transfusions.&#xD;
&#xD;
          7. Participation in other clinical studies within 3 months before admission to this&#xD;
             study.&#xD;
&#xD;
          8. The investigator considers it unsuitable for inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Wang, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Gao, PHD</last_name>
    <phone>0086-15209225834</phone>
    <email>gaowei2906@xjtufh.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiang Wang, PHD</last_name>
    <phone>0086-18049286968</phone>
    <email>dr.wangqiang@139.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>0931730000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yatao Liu, MD</last_name>
      <phone>0086-18152107860</phone>
    </contact>
    <investigator>
      <last_name>Yatao Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Cancer Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>0371450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xihua Lu, MD</last_name>
      <phone>0086-18539965618</phone>
    </contact>
    <investigator>
      <last_name>Xihua Lu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>0371450008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiaqiang zhang, PHD</last_name>
      <phone>0086-13937121360</phone>
    </contact>
    <investigator>
      <last_name>jiaqiang zhang, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qinghai University Affiliated Hospita</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <zip>0971810001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen Jia, MD</last_name>
      <phone>0086-13519702706</phone>
    </contact>
    <investigator>
      <last_name>Zhen Jia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaanxi Provincial People's Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>029710068</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rui Yang, MD</last_name>
      <phone>0086-13572135219</phone>
    </contact>
    <investigator>
      <last_name>Rui Yang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Xinjiang Uygur Autonomous Region</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiang</state>
        <zip>0991830001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guiping Xu, PHD</last_name>
      <phone>0086-13669988366</phone>
    </contact>
    <investigator>
      <last_name>Guiping Xu, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiang</state>
        <zip>0991830054</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Hong, PHD</last_name>
      <phone>0086-13009620188</phone>
    </contact>
    <investigator>
      <last_name>Yi Hong, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>September 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hyperlactacidemia</keyword>
  <keyword>Sodium bicarbonate Ringer's solution</keyword>
  <keyword>Acetate Ringer's solution</keyword>
  <keyword>hepatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlactatemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

